Fields AL - Search Results

1

Impact of Primary Container Closure System on PS80 Oxidation and the Mechanistic Understanding.

Mould R, Sargent PW Jr, Huang Y, Fields AL, Zhang L, Herbert FC, Stewart SL, Wang T. Mould R, et al. Among authors: fields al. Pharm Res. 2023 Aug;40(8):1965-1976. doi: 10.1007/s11095-023-03556-3. Epub 2023 Jul 11. Pharm Res. 2023. PMID: 37434039

2

Innovation in Healthcare Delivery: Commentary on an Evolutionary Approach.

Fields AL. Fields AL. Healthc Pap. 2015;15(2):16-20. doi: 10.12927/hcpap.2015.24418. Healthc Pap. 2015. PMID: 26853606

3

Does it Matter Whether Canada's Separate Health Technology Assessment Process for Cancer Drugs has an Economic Rationale?

Hoch JS, Beca J, Sabharwal M, Livingstone SW, Fields AL. Hoch JS, et al. Among authors: fields al. Pharmacoeconomics. 2015 Aug;33(8):879-82. doi: 10.1007/s40273-015-0278-7. Pharmacoeconomics. 2015. PMID: 25939500 Free PMC article. No abstract available.

4

Thrombocytopenia in the pediatric burn patient.

Warner P, Fields AL, Braun LC, James LE, Bailey JK, Yakuboff KP, Kagan RJ. Warner P, et al. Among authors: fields al. J Burn Care Res. 2011 May-Jun;32(3):410-4. doi: 10.1097/BCR.0b013e318217f91b. J Burn Care Res. 2011. PMID: 21422941

5

Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer.

Fields AL, Keller A, Schwartzberg L, Bernard S, Kardinal C, Cohen A, Schulz J, Eisenberg P, Forster J, Wissel P. Fields AL, et al. J Clin Oncol. 2009 Apr 20;27(12):1941-7. doi: 10.1200/JCO.2008.18.5710. Epub 2009 Mar 9. J Clin Oncol. 2009. PMID: 19273708 Clinical Trial.

6

Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials.

Mitry E, Fields AL, Bleiberg H, Labianca R, Portier G, Tu D, Nitti D, Torri V, Elias D, O'Callaghan C, Langer B, Martignoni G, Bouché O, Lazorthes F, Van Cutsem E, Bedenne L, Moore MJ, Rougier P. Mitry E, et al. Among authors: fields al. J Clin Oncol. 2008 Oct 20;26(30):4906-11. doi: 10.1200/JCO.2008.17.3781. Epub 2008 Sep 15. J Clin Oncol. 2008. PMID: 18794541 Clinical Trial.

7

Characterization of alterations of Rb2/p130 tumor suppressor in all-trans-retinoic acid resistant SK-OV3 ovarian carcinoma cells.

Fields AL, Soprano DR, Soprano KJ. Fields AL, et al. J Cell Physiol. 2008 Oct;217(1):77-85. doi: 10.1002/jcp.21477. J Cell Physiol. 2008. PMID: 18446820

8

Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC).

Fields AL, Einstein MH, Novetsky AP, Gebb J, Goldberg GL. Fields AL, et al. Gynecol Oncol. 2008 Jan;108(1):201-6. doi: 10.1016/j.ygyno.2007.09.025. Epub 2007 Nov 8. Gynecol Oncol. 2008. PMID: 17997145 Clinical Trial.

9

Retinoids in biological control and cancer.

Fields AL, Soprano DR, Soprano KJ. Fields AL, et al. J Cell Biochem. 2007 Nov 1;102(4):886-98. doi: 10.1002/jcb.21530. J Cell Biochem. 2007. PMID: 17902161 Review.

10

Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.

Saltz LB, Niedzwiecki D, Hollis D, Goldberg RM, Hantel A, Thomas JP, Fields AL, Mayer RJ. Saltz LB, et al. Among authors: fields al. J Clin Oncol. 2007 Aug 10;25(23):3456-61. doi: 10.1200/JCO.2007.11.2144. J Clin Oncol. 2007. PMID: 17687149 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page